Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study
Joan Carles, S. Serradell, Sònia Servitja, Alex Martínez‐Martí et al.
Citations
6 citations
Journal
The Lancet Regional Health - Europe
Topics
Frailty in Older Adults
Field-Weighted Citation Impact (FWCI)
2.07
article
Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study
Joan Carles, S. Serradell, Sònia Servitja, Alex Martínez‐Martí, M.A. Rezqallah Aron, Sergio Bueno, Alberto Hernando‐Calvo, Josep M. Tabernero, María Roca, Diego Gómez-Puerto, Guillermo Villacampa, Élena Elez, R. Burgos, Anna Pedrola, David Páez, Gaspar Molina, Judit Sanz-Beltran, Ada Alonso, D. López-Valbuena, Eva Muñoz‐Couselo, P. Gómez Pardo, Elena Garralda, L. Andurell, Ana Oaknin, C. Salva de Torres, Oriol Mirallas, Roger Berché, Jordi Recuero-Borau, Teresa Macarulla, Cristina Saura, Berta Martín-Cullell, Cristina Viaplana, Simeón Eremiev, Rodrigo Dienstmann, Enriqueta Felip, Vı́ctor Navarro, José María Ucha, Kreina Sharela Vega, Ángeles Peñuelas, Fiorella Palmas, Rafael Bach
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Regional Health - EuropeVol. 46
Institutions
Hospital de Sant Pau (ES), Vall d'Hebron Hospital Universitari (ES), Hospital Del Mar (ES), Vall d'Hebron Institute of Oncology (ES)
Funders
Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Celgene, Regeneron Pharmaceuticals, Exelixis, Jazz Pharmaceuticals, Novocure, Les Laboratories Pierre Fabre, Clovis Oncology, Deciphera Pharmaceuticals, Mersana Therapeutics, Myriad Genetics, Incyte, Seagen, Eisai, Servier, PharmaMar, Ipsen, LEO Pharma, Genentech, Daiichi Sankyo Europe